MESA LABORATORIES INC /CO/
No enriched coverage for $MLAB in the last 7 days.
No SEC Form 4 filings for $MLAB in the last 30 days.
See all $MLAB insider activity →Mesa Laboratories (NASDAQ:MLAB) announced its board declared a regular quarterly dividend of $0.16 per share of common stock. The dividend is payable Sept. 15, 2026, to shareholders of record as of Aug. 31, 2026. The company said the payment reflects its ongoing capital return policy.
Archbold Brian David (SVP Operations) sold 2,516 shares of MESA LABORATORIES INC /CO/ (MLAB) at $89.50 ($0.23M total) on 2026-06-22.
MESA LABORATORIES INC /CO/ (MLAB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex_977035.htm EXHIBIT 10.1 ex_977035.htm Exhibit 10.1 FORM OF EXECUTIVE EMPLOYMENT AGREEMENT Mesa Laboratories, Inc. This Executive Employment Agreement (the “ Agreement ”) is entered into and effective on [●] (the “ Effective Date ”) by and between Mesa Laboratories, I
Recent MLAB coverage spans financial news, corporate actions and insider activity.
Dividend declaration is a direct, company-specific capital return update that can modestly affect near-term price and income positioning.
Routine insider open-market sale under a Form 4; typically more of a sentiment/positioning signal than a fundamental catalyst.
The filing discloses a new executive employment arrangement for the Chief Accounting Officer role, which can affect internal controls, reporting cadence, and governance optics.
Strong profitability and deleveraging in FY26, but near-term revenue quality risk from BPD export-control delays and commercial execution issues.
Mesa Laboratories has declared a quarterly dividend of $0.16 per share, payable on June 15, 2026. This signals financial stability and shareholder value focus, which may positively influence investor sentiment.
alphai scores every news story that mentions MLAB with an AI model for sentiment and relevance, and aggregates insider trades from MESA LABORATORIES INC /CO/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Mesa Laboratories (NASDAQ:MLAB) announced its board declared a regular quarterly dividend of $0.16 per share of common stock. The dividend is payable Sept. 15, 2026, to shareholders of record as of Aug. 31, 2026. The company said the payment reflects its ongoing capital return policy.
2 min readArchbold Brian David (SVP Operations) sold 2,516 shares of MESA LABORATORIES INC /CO/ (MLAB) at $89.50 ($0.23M total) on 2026-06-22.
2 min readMESA LABORATORIES INC /CO/ (MLAB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex_977035.htm EXHIBIT 10.1 ex_977035.htm Exhibit 10.1 FORM OF EXECUTIVE EMPLOYMENT AGREEMENT Mesa Laboratories, Inc. This Executive Employment Agreement (the “ Agreement ”) is entered into and effective on [●] (the “ Effective Date ”) by and between Mesa Laboratories, I
3 min readMesa Laboratories (NASDAQ:MLAB) reported 4Q26 revenues up 2.6% to $63.7M and FY26 revenues up 3.4% to $249.1M. Operating income rose 87% to $2.75M in 4Q26 and 13.3% to $18.5M in FY26. Non-GAAP AOI excluding unusual items increased 49.2% (4Q26) and 11.9% (FY26); FY26 free cash flow was $39.6M, used mainly to repay $14.7M debt, reducing net leverage to 2.11.
3 min readMesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. This dividend will be payable on June 15, 2026, to shareholders who are of record at the close of business on May 29, 2026. The announcement was made on April 3, 2026.
1 min readMesa Laboratories announced that CEO Gary Owens will step down on April 12, 2026, after leading the company since 2017. Dr. Siddhartha Kadia has been appointed as the new President, CEO, and director, effective April 13, 2026, with a compensation package designed to drive the company's next phase of growth. Spark’s AI Analyst rates MLAB stock as Neutral, citing strong cash generation but unstable net earnings and mixed technical momentum.
2 min readLAKEWOOD, Colo., Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- Mesa Laboratories, Inc. ( NASDAQ:MLAB ) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcoming conferences: ...
2 min readLAKEWOOD, Colo., Oct. 03, 2025 ( GLOBE NEWSWIRE ) -- Mesa Laboratories, Inc. ( NASDAQ:MLAB ) will issue a press release with financial results for the second quarter of fiscal year 2026 following market close on Thursday, November 6, 2025.
2 min readLakewood, Colo., Oct. 03, 2025 ( GLOBE NEWSWIRE ) -- Mesa Laboratories, Inc. ( NASDAQ:MLAB ) ( we, us, our, "Mesa" or the "Company" ) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.
2 min readLAKEWOOD, Colo., Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- Mesa Laboratories, Inc. MLAB ( we, us, our, "Mesa" or the "Company" ) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company's 1.375% Convertible Senior ...
3 min read
